Front Page

In a significant move for the global medtech landscape, the European Commission has initiated a targeted revision of the Medical Devices Regulation (MDR) and In Vitro Diagnostic Medical Devices Regulation (IVDR). This response to widespread calls from the medtech sector aims to streamline regulatory processes, cut costs, and expedite market...

Inaphaea BioLabs, the wholly owned translational Contract Research Organisation of ValiRx Plc, has announced a series of major initiatives over the past three months that significantly advance its role in translational cancer research, drug discovery, and personalised medicine. Under the leadership of Mark Eccleston, the recently appointed CEO of parent...

Following the delivery of its first cohort and strong demand for Cohort 2, Medilink Midlands is now welcoming applications for Cohort 3 of its venture readiness programme, the Medilink Midlands Innovation Builder (MMIB), launching in early 2026. MMIB has quickly become a valued route for health and medtech innovators to...

On Thursday 11 September, Medilink Midlands was honoured to receive the Outstanding Contribution to Life Sciences Award at the Life Sciences Gala Dinner & Awards, part of Life Sciences Week 2025 – a week-long programme of events celebrating the region’s life sciences excellence. The Gala Dinner brought together organisations and...

Medilink Midlands has celebrated another hugely successful Innovation Day, the Midlands' flagship life sciences and medtech conference and exhibition. Held on Wednesday 17 September at Villa Park, Birmingham, the event brought together over 250 delegates for a full day of sector insight, networking, exhibitions, and expert-led workshops. As part of...

WMHTC today announced a significant transition in its leadership and ownership structure. The current Executive Chair of WMHTC, David Kidney, will be stepping down, marking the end of a pivotal chapter in the organisation’s journey. Effective 1 October 2025, WMHTC will be operated under the stewardship of Medilink Midlands. This...

Pennine Healthcare, one of the UK’s leading employee-owned medical device manufacturers, was proud to welcome Sir Nicholas Dakin, Government Whip, Lord Commissioner of HM Treasury, and Parliamentary Under-Secretary (Ministry of Justice), to its Derby headquarters last week. The visit highlighted the success of Pennine’s Release on Temporary Licence (ROTL) Scheme,...

Nottingham, UK – 11th September 2025 – Upperton Pharma Solutions has added another impressive award to a growing list of achievements, winning the award for Pharma Contract Services Company of the Year at the Pharma Industry Awards UK and nominated finalist for Pharma Company of the Year. This year marks...

Health Innovation East Midlands and Medilink Midlands are delighted to confirm the signing of a renewed Memorandum of Understanding, marking a strengthened collaboration to drive life sciences and health innovation across the East Midlands. Together, we will develop a joint proposition for consideration by the East Midlands Combined Authority and...

Haughton Design, a leading UK-based product design consultancy specialising in medical devices, drug delivery systems and healthcare technology, has appointed Dr Ash Ghadar as Chief Executive Officer (CEO) to lead the company’s next phase of growth in the MedTech and Pharmaceutical sectors. Dr Ghadar joined Haughton Design in January 2025 as...